NewAmsterdam Pharma (NASDAQ:NAMS) Downgraded by Wall Street Zen to “Sell”
NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday. A number of other equities analysts have also weighed in on the stock. Stifel Nicolaus began coverage on shares of NewAmsterdam Pharma in a […]
NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday. A number of other equities analysts have also weighed in on the stock. Stifel Nicolaus began coverage on shares of NewAmsterdam Pharma in a […]
